{"ticker": {"uuid": "fc0fa77a-c960-40a7-9172-1e7d86b3d854", "symbol": "BEAT", "name": "Heartbeam Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Health Information Services"}, "articles": [{"title": "Halliburton Co. (NYSE:HAL) Reports In-Line Q2 Earnings and Revenue Beat, Shares Fall on Geopolitical Risks", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxQNkZJWkREOXVtam9KYTBIQzd5VHJaeGx3Mkh3UFAwVm9xNW1PeVIza0gxQmg1Q1VlcWU5bnhvSnp5dTJMcWs1QXo0d0FXWVlwNGd3WWZRWTRxTlRnWlhhOEhUendCOFo5WGdXZHFhTzV1dEV5VzUyN0N4NlcwNU92cWM5bUd6NVhnaExVenBpNXBfcXY0Nm1KU2thM1FvVnludzZFcXNtZ1VCRFU5ZThEVW1jNnJMUHUwQWhmdVRlSDFaRzlSMFQ2aUUtSkNvYUtCRkpvaTc1SENSVzRqYkcxdmdORTJyaWM?oc=5", "source_name": "ChartMill", "published_at": "2026-07-21T11:21:23+00:00", "published_display": "21 Jul 2026 11:21", "sentiment": "negative", "sentiment_pct": 22, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Heartbeam, Inc. (BEAT) Q4 2023 Earnings Report - Results, Call & Slides", "summary": "Heartbeam, Inc. (BEAT) announced its Q4 2023 earnings, reporting an actual EPS of $0.07, significantly beating the consensus EPS of -$0.12", "url": "https://www.tipranks.com/stocks/beat/earnings/q4-2023-report", "source_name": "TipRanks", "published_at": "2026-07-20T16:12:09", "published_display": "20 Jul 2026 16:12", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BEAT Initiated Coverage by Maxim Group -- Price Target Announced at $2.00", "summary": "Maxim Group has initiated coverage on HeartBeam (BEAT) with a 'Buy' rating and a price target of $2.00, signaling confidence in the company's growth potential. This comes despite HeartBeam's low GF Score\u2122 of 26/100, which indicates weaknesses in profitability and growth, but a st", "url": "https://www.gurufocus.com/news/8958233/beat-initiated-coverage-by-maxim-group-price-target-announced-at-200", "source_name": "GuruFocus", "published_at": "2026-07-14T17:10:41", "published_display": "14 Jul 2026 17:10", "sentiment": "positive", "sentiment_pct": 73, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeartBeam receives patent for multi-modal cardiac sensing device", "summary": "HeartBeam Inc. has been granted a U.S. patent for a multi-modal cardiac sensing device that integrates acoustic sensing and thoracic impedance measurements into its credit card-sized ECG device. This new technology aims to improve the management of heart failure by detecting hear", "url": "https://www.investing.com/news/company-news/heartbeam-receives-patent-for-multimodal-cardiac-sensing-device-93CH-4790499", "source_name": "Investing.com", "published_at": "2026-07-14T12:10:41", "published_display": "14 Jul 2026 12:10", "sentiment": "positive", "sentiment_pct": 64, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeartBeam Awarded New U.S. Patent Expanding Acoustic Sensing and Fluid Monitoring Capabilities of Its Cable-Free ECG Device", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/heartbeam-awarded-u-patent-expanding-110000423.html", "source_name": "Business Wire", "published_at": "2026-07-14T11:00:00+00:00", "published_display": "14 Jul 2026 11:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeartBeam patent covers credit-card-sized ECG for digital stethoscope use", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxNaklCN0VQeHdQdnhJLVlkcWhYRThmWFFSSXBWVEVYeEdXTE9ERDdIaW1CMDE2MWF1ajJHbThhYm5PckF0QkVnYi1ydUFEV3I4akVSNm9MbFJrc1RNY2RZRFN0UFRtUGUxYzhZU2Fjd0lKcmlaRWNwaXpQOGpkVjJUSHFETzZteW94X05kLWNuWEVWUVJ2WWZNbXZ4cEtGaldfN1lpb1I1c1pIa25oRjh0NlNYYURaNXBpV0pv?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-14T11:00:00+00:00", "published_display": "14 Jul 2026 11:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Heartbeam Inc. (BEAT) Stock Price | Live Quotes & Charts | NASDAQ", "summary": "This page provides live quotes and charts for Heartbeam Inc. (BEAT) stock, which is currently trading at $0.6369 with a slight decrease. It notes that there are no analyst ratings or earnings information currently available for the company. The rest of the page primarily consists", "url": "https://timothysykes.com/quote/BEAT/", "source_name": "timothysykes.com", "published_at": "2026-07-09T23:10:36", "published_display": "09 Jul 2026 23:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeartBeam (NASDAQ: BEAT) Completes Enrollment Ahead of Schedule in Heart Attack Detection Pilot Study", "summary": "HeartBeam (NASDAQ: BEAT) has completed patient enrollment ahead of schedule for its ALIGN-ACS pilot study, which evaluates the HeartBeam System for heart attack detection. The study enrolled 120 patients and data analysis is now underway, with results expected to be presented at ", "url": "https://www.theglobeandmail.com/investing/markets/stocks/BEAT/pressreleases/3059326/heartbeam-nasdaq-beat-completes-enrollment-ahead-of-schedule-in-heart-attack-detection-pilot-study/", "source_name": "The Globe and Mail", "published_at": "2026-07-05T00:41:03", "published_display": "05 Jul 2026 00:41", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nasdaq warns HeartBeam (NASDAQ: BEAT) over $1 minimum bid price rule", "summary": "HeartBeam, Inc. (NASDAQ: BEAT) has received a notice from Nasdaq stating that its common stock is not in compliance with the exchange's minimum $1.00 bid price requirement, having traded below this level for 30 consecutive business days. The company has 180 calendar days, until D", "url": "https://www.stocktitan.net/sec-filings/BEAT/8-k-heart-beam-inc-reports-material-event-e8a1369abf91.html", "source_name": "Stock Titan", "published_at": "2026-07-02T20:40:47", "published_display": "02 Jul 2026 20:40", "sentiment": "negative", "sentiment_pct": 36, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeartBeam Disclosed Failure to Satisfy a Continued Listing Rule or Standard", "summary": "HeartBeam (BEAT) received a Nasdaq deficiency notice on June 30, 2026, for failing to maintain a minimum bid price of $1.00 for 30 consecutive business days. The company has 180 days, until December 28, 2026, to regain compliance, with a possibility of an extension. This informat", "url": "https://www.tradingview.com/news/tradingview:c958b024bea56:0-heartbeam-disclosed-failure-to-satisfy-a-continued-listing-rule-or-standard/", "source_name": "TradingView", "published_at": "2026-07-02T20:40:47", "published_display": "02 Jul 2026 20:40", "sentiment": "negative", "sentiment_pct": 14, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Heartbeam, Inc. Warrant 2021-31.10.26 on HeartBeam Financial Disclosures & SEC Filings", "summary": "This page provides access to Heartbeam, Inc.'s SEC filings and other important company documents, such as Forms 10-K, 10-Q, and 8-K. Investors can review these disclosures to evaluate the company's financial performance and operational updates. The documents span from 2021 to 202", "url": "https://www.tradingview.com/symbols/NASDAQ-BEATW/documents/", "source_name": "TradingView", "published_at": "2026-07-02T19:11:35", "published_display": "02 Jul 2026 19:11", "sentiment": "positive", "sentiment_pct": 65, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeartBeam (BEAT) Advances Modern Cardiac Care, Expanding Use of ECG Data Outside of the Hospital", "summary": "HeartBeam (NASDAQ: BEAT) is developing technologies to expand the use of ECG data beyond hospital settings, focusing on timely and actionable insights for cardiac care. Their proprietary, FDA-cleared HeartBeam System is a portable, cable-free ECG system that synthesizes a 12-lead", "url": "https://finance.yahoo.com/healthcare/articles/heartbeam-beat-advances-modern-cardiac-174042972.html", "source_name": "Market source", "published_at": "2026-07-01T17:39:20", "published_display": "01 Jul 2026 17:39", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeartBeam completes enrollment in heart attack detection study", "summary": "HeartBeam, Inc. has completed patient enrollment in its ALIGN-ACS pilot study, evaluating its HeartBeam System for heart attack detection ahead of schedule. The study involved 120 patients in Serbia and its findings will inform a planned pivotal study in the U.S. and support a fu", "url": "https://www.investing.com/news/company-news/heartbeam-completes-enrollment-in-heart-attack-detection-study-93CH-4767485", "source_name": "Investing.com", "published_at": "2026-06-30T21:39:20", "published_display": "30 Jun 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeartBeam (BEAT) Completes Enrollment Ahead of Schedule in Heart Attack Detection Pilot Study", "summary": "HeartBeam (NASDAQ: BEAT) has successfully completed patient enrollment for its ALIGN-ACS pilot study, which evaluates the HeartBeam System for heart attack detection, ahead of its scheduled timeline. The study included 120 patients at two sites in Serbia, utilizing both standard ", "url": "https://www.newmediawire.com/news/heartbeam-beat-completes-enrollment-ahead-of-schedule-in-heart-attack-detection-pilot-study-7087440", "source_name": "NewMediaWire", "published_at": "2026-06-30T21:10:04", "published_display": "30 Jun 2026 21:10", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeartBeam (BEAT) FDA Approvals, PDUFA Dates & Drug Alerts 2026 $BEAT", "summary": "This article details the FDA approval process and regulatory events for HeartBeam (BEAT), focusing on two key therapies: ALIGN-ACS for heart attack detection and the HeartBeam system for comprehensive arrhythmia assessment. It highlights the recent completion of patient enrollmen", "url": "https://www.marketbeat.com/stocks/NASDAQ/BEAT/fda-events/?drug=ALIGNACS&anchor=fda-alignacs-2026-06-30", "source_name": "MarketBeat", "published_at": "2026-06-30T17:09:48", "published_display": "30 Jun 2026 17:09", "sentiment": "positive", "sentiment_pct": 70, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule", "summary": "HeartBeam, Inc. has completed patient enrollment in its ALIGN-ACS pilot study for heart attack detection ahead of schedule, evaluating its 3D ECG technology. Data analysis is currently underway, with full results expected to be presented at a cardiology conference later this year", "url": "https://www.businesswire.com/news/home/20260630151674/en/HeartBeam-Completes-Enrollment-in-Heart-Attack-Detection-Pilot-Study-Ahead-of-Schedule", "source_name": "Business Wire", "published_at": "2026-06-30T11:09:48", "published_display": "30 Jun 2026 11:09", "sentiment": "positive", "sentiment_pct": 73, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeartBeam (BEAT) Stock Sees Fair Value Cut As Analysts Weigh Dilution And Slower Ramp", "summary": "HeartBeam (BEAT) recently saw its fair value estimate cut by analysts from $5.08 to $3.83 per share, primarily due to recent equity offerings causing dilution and a slower-than-expected revenue ramp. Despite these reductions, some analysts maintain bullish ratings, citing a solid", "url": "https://finance.yahoo.com/markets/stocks/articles/heartbeam-beat-stock-sees-fair-130837826.html", "source_name": "Market source", "published_at": "2026-06-27T12:08:00", "published_display": "27 Jun 2026 12:08", "sentiment": "negative", "sentiment_pct": 29, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeartBeam, Inc. Actuals & Estimates (NASDAQ:BEAT)", "summary": "This article provides an in-depth financial overview of HeartBeam, Inc. (NASDAQ:BEAT), including its current stock price, historical performance, analyst forecasts, and key financial metrics like market capitalization, earnings, and revenue. It highlights a significant decrease i", "url": "https://www.tradingview.com/symbols/NASDAQ-BEAT/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-25T16:40:04", "published_display": "25 Jun 2026 16:40", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeartBeam (BEAT) Reorganizes to Accelerate Global Commercialization Strategy", "summary": "HeartBeam (NASDAQ: BEAT) announced a strategic reorganization to accelerate its global commercialization strategy for its cardiac monitoring technology. This includes streamlining decision-making, improving accountability, and reducing costs, with founder Branislav Vajdic, Ph.D.,", "url": "https://finance.yahoo.com/healthcare/articles/heartbeam-beat-reorganizes-accelerate-global-194000521.html", "source_name": "Market source", "published_at": "2026-06-25T03:09:42", "published_display": "25 Jun 2026 03:09", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Leadership shakeup as HeartBeam (NASDAQ: BEAT) reorganizes for global ECG push", "summary": "HeartBeam, Inc. (NASDAQ: BEAT) announced a strategic reorganization to accelerate global adoption of its ambulatory ECG signal platform and improve capital efficiency. CEO Robert P. Eno will depart on June 30, 2026, with Founder and President Branislav Vajdic, Ph.D., taking over ", "url": "https://www.stocktitan.net/sec-filings/BEAT/8-k-heart-beam-inc-reports-material-event-65ec711f0321.html", "source_name": "Stock Titan", "published_at": "2026-06-24T21:11:21", "published_display": "24 Jun 2026 21:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeartBeam Announces Strategic Shift to Accelerate Global Adoption of its Ambulatory ECG Signal Platform and Leadership Transition", "summary": "HeartBeam, Inc. has announced a strategic reorganization to accelerate the global adoption of its ambulatory ECG signal platform, moving beyond direct medical device sales to license its 3D ECG technology to established partners. The company aims to broaden its market reach, focu", "url": "https://www.businesswire.com/news/home/20260624011757/en/HeartBeam-Announces-Strategic-Shift-to-Accelerate-Global-Adoption-of-its-Ambulatory-ECG-Signal-Platform-and-Leadership-Transition", "source_name": "Business Wire", "published_at": "2026-06-24T20:11:21", "published_display": "24 Jun 2026 20:11", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeartBeam (NASDAQ: BEAT) Launches Study Focused on Testing Proprietary Patch Capable of Generating On-Demand 12-Lead ECG for Ischemia Detection", "summary": "HeartBeam (NASDAQ: BEAT) has initiated a pilot study to evaluate its proprietary on-demand 12-lead ECG patch for detecting coronary artery disease and ischemia. This technology aims to provide clinical-grade insights over extended periods, an advancement not previously possible w", "url": "https://www.tradingview.com/news/financewire:d138b2176094b:0-heartbeam-nasdaq-beat-launches-study-focused-on-testing-proprietary-patch-capable-of-generating-on-demand-12-lead-ecg-for-ischemia-detection/", "source_name": "TradingView", "published_at": "2026-06-23T17:42:06", "published_display": "23 Jun 2026 17:42", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeartBeam (BEAT) Launches Study Focused on Testing Proprietary Patch Capable of Generating On-Demand 12-Lead ECG for Ischemia Detection", "summary": "HeartBeam (NASDAQ: BEAT) has initiated a pilot study to evaluate its proprietary on-demand 12-lead ECG patch for detecting coronary artery disease and ischemia. This study aims to address the urgent and widespread health threat of coronary artery disease by providing a faster and", "url": "https://finance.yahoo.com/healthcare/articles/heartbeam-beat-launches-study-focused-181500690.html", "source_name": "Market source", "published_at": "2026-06-23T14:15:00", "published_display": "23 Jun 2026 14:15", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[8-K] HeartBeam, Inc. Reports Material Event", "summary": "HeartBeam, Inc. announced new compensation arrangements for its President, Founder, and Director, Dr. Branislav Vajdic, including a performance-based restricted stock unit (PRSU) award and a Transaction Bonus Agreement. The PRSUs, totaling 2,800,000 units, are contingent on achie", "url": "https://www.stocktitan.net/sec-filings/BEAT/8-k-heart-beam-inc-reports-material-event-67a8b1056ce0.html", "source_name": "Stock Titan", "published_at": "2026-06-23T05:39:35", "published_display": "23 Jun 2026 05:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BEATW | Heartbeam, Inc. Warrant Insider Trading", "summary": "This Quiver Quantitative page provides an overview of Heartbeam, Inc. Warrant (BEATW) focusing on insider trading activity, institutional holdings, analyst ratings, and company financials. It indicates no recent insider trading for this specific ticker and lists institutional own", "url": "https://www.quiverquant.com/stock/BEATW/insiders/", "source_name": "Quiver Quantitative", "published_at": "2026-06-21T21:09:44", "published_display": "21 Jun 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Heartbeam Inc (BEATW) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of Heartbeam Inc (BEATW)'s dividend and stock split history. It states that no dividend data or stock split data is available for the company. The article also includes current stock price information and links to various financial news and analy", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-beatw/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-19T16:10:19", "published_display": "19 Jun 2026 16:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Heartbeam Inc (BEATW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article from TradingKey attempts to provide a revenue breakdown for Heartbeam Inc (BEATW), including business segments, regional revenue, and profit contribution. However, the article states that relevant data for these categories have not been disclosed by the company yet. ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-beatw/revenue", "source_name": "TradingKey", "published_at": "2026-06-19T09:11:02", "published_display": "19 Jun 2026 09:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeartBeam (NASDAQ: BEAT) seeks approval for 3M-share equity plan increase at 2026 meeting", "summary": "HeartBeam, Inc. (NASDAQ: BEAT) is seeking shareholder approval to amend its 2022 Equity Incentive Plan to increase the number of authorized shares by 3,000,000, bringing the total capacity to 14,900,000 shares. This proposal, discussed in a definitive proxy statement for the July", "url": "https://www.stocktitan.net/sec-filings/BEAT/def-14a-heart-beam-inc-definitive-proxy-statement-90b5fb217190.html", "source_name": "Stock Titan", "published_at": "2026-06-18T20:46:10", "published_display": "18 Jun 2026 20:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Heartbeam Inc (BEAT) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of Heartbeam Inc (BEAT), focusing on support, resistance, indicators, and moving averages. While relevant data for support and resistance have not been disclosed, the analysis covers various technical indicators like MACD, RSI, and KDJ, ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-beat/technical", "source_name": "TradingKey", "published_at": "2026-06-18T14:46:10", "published_display": "18 Jun 2026 14:46", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Heartbeam Inc (BEATW) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "This article from TradingKey provides an earnings forecast for Heartbeam Inc (BEATW), focusing on future EPS and revenue growth estimates. However, the report states that relevant data for financial forecasting metrics such as EPS, revenue, net profit, and EBIT have not been disc", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-beatw/earnings", "source_name": "TradingKey", "published_at": "2026-06-18T03:39:30", "published_display": "18 Jun 2026 03:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Heartbeam Inc (BEAT) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides historical payout information for Heartbeam Inc (BEAT) regarding dividends and stock splits. It states that Heartbeam Inc has not distributed any dividends over the past five years and has no recorded stock split data. The page also presents current stock pe", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-beat/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-17T21:10:43", "published_display": "17 Jun 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Heartbeam Inc (BEAT) Institutional Confidence", "summary": "This article from TradingKey provides a snapshot of institutional confidence in Heartbeam Inc (BEAT). It details key institutional shareholders and their shareholdings, noting changes for some, such as BlackRock and UBS Financial Services. The data offers insights into institutio", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-beat/sentiment", "source_name": "TradingKey", "published_at": "2026-06-17T20:10:43", "published_display": "17 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Heartbeam Inc (BEATW) Financial Health: Profitability & Balance Sheet Analysis", "summary": "The article provides an overview of Heartbeam Inc (BEATW) financial health, focusing on profitability and balance sheet analysis. It notes that relevant financial data regarding cash, assets, liabilities, revenue, operating profit, and cash flow has not yet been disclosed by the ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-beatw/financial-health", "source_name": "TradingKey", "published_at": "2026-06-17T09:11:15", "published_display": "17 Jun 2026 09:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeartBeam (BEAT) Study Shows Portable ECG Device Can Help Identify Heart Attack Risk", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/heartbeam-beat-study-shows-portable-150820463.html", "source_name": "NewMediaWire", "published_at": "2026-06-03T15:08:20+00:00", "published_display": "03 Jun 2026 15:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeartBeam reaches 4 U.S. markets through Cedars-Sinai-linked clinic", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNRW5YRWtHcExwRm85ZVhIUHVSSVZRXzdUTTJKM0ttUTg1YnAzT3NsRkVQODk2Mzk5ZmpFZThQQ0ZqalhnVHIzYklCTE1rNlRIVGpEQVJ6QnVaeEFLaWM4dFFGbXIxQUtMSndUbzlNSXM0Ymp0NHVLMjl1VjJQWldlYWFWWjB2YU5haDZqeUZLcThBY082T05ZMnowb0pfOVNKZWNTSjgtWDdXeU03Yml1Z0dEMDgyLUlQSlI3Zm1n?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeartBeam Announces Closing of $10 Million Public Offering of Common Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxOVVpPN051NE14MUp4ZFhlZVQ0bGtKZS01bmpnbVdpZVg1QTNNSXZxZktnb0w2SWRGU0U3NlpaNmpBR1pnanFhSGVmcGJLN1dEU2JEMEJLc3RrM3JMVVZDYlI5aElTQlhPTzJYMDFSV1BwZVU0eVRVbk5mZXNHOU9qelRXVUxaOE8tajhBQXBiemw5bjZmQVFUaUkzdXZJRGZ0eVZWZ1ZGSmFKenJJdTl1SllZRl9PajZtcm5kU0xRTW1pX003M0VIaU1Qbkh6UQ?oc=5", "source_name": "Business Wire", "published_at": "2026-04-16T07:00:00+00:00", "published_display": "16 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeartBeam Announces Pricing of $10 Million Public Offering of Common Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxObFl0T2lYQk1GQnV2Y3FNVnVHeWE5aFFaV3h1SU81X2Vud2tiOXBuRHgyQ1YzWnF5QmJ2R2RHaWpSZ1FqTDBuVWNGa0Q1SlZKYzB4T3dPNlZtejg5WWQzd0g4MmtoMlU4WWwyRGlNMG10d0xlUjJyVVdFeEZHei1LcGpsbzJSaVdzbTlweVowTk5mSjFFRGp2QzJjZy1Gbjl0N1YtaFA5ckk3ZGZhcFRUb3RmUDJjUXNfVWRaYTQ0eC1hbW54YVVJdUNMNV95UQ?oc=5", "source_name": "Business Wire", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeartBeam seeks fresh capital for FDA-cleared ECG rollout", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPTThGMkN4VVc4OXFlcnNjc2EwUHlvRG9veFBvSldWMVlCLVNaMWxSMEstSEdzel80WU1oRWRVUDRCX1luTVFFVnBHaFFLanBrR0ttMEtuMWRLMm9MdVQ4bk10WjBzcV9jaUZIcloxUm1RMzVfMmRuZEJpSHB3Rlp4Q2RyazVYcWt6RmpfRUw5MkM2TGVpT042LV9heUtzUG1XbEZNczhoQWZBRVk2SFY4?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New HeartBeam\u2013Mount Sinai project brings hospital-grade heart checks home", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxNR1lRcGltRk1UQkw0SV9YdjVrTW5YREpwb3ZLMkRPZGM3Y0ZwT2RFeVhZaURKV0JHU182UmtUYVBXaUxMSGFDUjFyTGl4c3J3LWd0MUJ5X3JqRU8zUVQ2V2ZCRXlWeXZwdlFwYVlVVTJVTmhLem14eW1fMWZvVG9Tdzl3VldjbkV0MXRNb3M3RzIwR0Q1VzZLUXVBQVlLLUtmdVU1R21HNVNaMzN1aVlFVTBKX2l2VEFub2tsSg?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeartBeam raising $10M for FDA-cleared health tech with public offering", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxNdWhYRHNTTkxqTC1JSlpET1I4NkVyc09KYk5zcE5hN3hlWXpMNFlhUWpncTdFSGF6U0tvWTBSdmh0dHhBbUVCZFUwaXlVbHdXWl9LRzJWbFBiTk9JT3Y3SjV4RGVHSnRNczUxOC1TMjdMU0pzejllVF85eEVFVElBWG82Zk1ZVDVsTjZwVTRTT01laXlka2FXQVVYUGF4MGpaNFpVaWpiMDJ2elJ1QTJVci03QnhpWUhVSHpWSGtXLXVTYkpYRndmTjNaMThOY0YyTEpsWU5md21PaG1Dbm1R?oc=5", "source_name": "Cardiovascular Business", "published_at": "2025-02-13T08:00:00+00:00", "published_display": "13 Feb 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Halliburton Co. (NYSE:HAL) Reports In-Line Q2 Earnings and Revenue Beat, Shares Fall on Geopolitical Risks", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5wFBVV95cUxQNkZJWkREOXVtam9KYTBIQzd5VHJaeGx3Mkh3UFAwVm9xNW1PeVIza0gxQmg1Q1VlcWU5bnhvSnp5dTJMcWs1QXo0d0FXWVlwNGd3WWZRWTRxTlRnWlhhOEhUendCOFo5WGdXZHFhTzV1dEV5VzUyN0N4NlcwNU92cWM5bUd6NVhnaExVenBpNXBfcXY0Nm1KU2thM1FvVnludzZFcXNtZ1VCRFU5ZThEVW1jNnJMUHUwQWhmdVRlSDFaRzlSMFQ2aUUtSkNvYUtCRkpvaTc1SENSVzRqYkcxdmdORTJyaWM?oc=5", "source_name": "ChartMill", "published_at": "2026-07-21T11:21:23+00:00", "published_display": "21 Jul 2026 11:21", "sentiment": "negative", "sentiment_pct": 22, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Heartbeam, Inc. (BEAT) Q4 2023 Earnings Report - Results, Call & Slides", "summary": "Heartbeam, Inc. (BEAT) announced its Q4 2023 earnings, reporting an actual EPS of $0.07, significantly beating the consensus EPS of -$0.12", "url": "https://www.tipranks.com/stocks/beat/earnings/q4-2023-report", "source_name": "TipRanks", "published_at": "2026-07-20T16:12:09", "published_display": "20 Jul 2026 16:12", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BEAT Initiated Coverage by Maxim Group -- Price Target Announced at $2.00", "summary": "Maxim Group has initiated coverage on HeartBeam (BEAT) with a 'Buy' rating and a price target of $2.00, signaling confidence in the company's growth potential. This comes despite HeartBeam's low GF Score\u2122 of 26/100, which indicates weaknesses in profitability and growth, but a st", "url": "https://www.gurufocus.com/news/8958233/beat-initiated-coverage-by-maxim-group-price-target-announced-at-200", "source_name": "GuruFocus", "published_at": "2026-07-14T17:10:41", "published_display": "14 Jul 2026 17:10", "sentiment": "positive", "sentiment_pct": 73, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeartBeam receives patent for multi-modal cardiac sensing device", "summary": "HeartBeam Inc. has been granted a U.S. patent for a multi-modal cardiac sensing device that integrates acoustic sensing and thoracic impedance measurements into its credit card-sized ECG device. This new technology aims to improve the management of heart failure by detecting hear", "url": "https://www.investing.com/news/company-news/heartbeam-receives-patent-for-multimodal-cardiac-sensing-device-93CH-4790499", "source_name": "Investing.com", "published_at": "2026-07-14T12:10:41", "published_display": "14 Jul 2026 12:10", "sentiment": "positive", "sentiment_pct": 64, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeartBeam Awarded New U.S. Patent Expanding Acoustic Sensing and Fluid Monitoring Capabilities of Its Cable-Free ECG Device", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/heartbeam-awarded-u-patent-expanding-110000423.html", "source_name": "Business Wire", "published_at": "2026-07-14T11:00:00+00:00", "published_display": "14 Jul 2026 11:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeartBeam patent covers credit-card-sized ECG for digital stethoscope use", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxNaklCN0VQeHdQdnhJLVlkcWhYRThmWFFSSXBWVEVYeEdXTE9ERDdIaW1CMDE2MWF1ajJHbThhYm5PckF0QkVnYi1ydUFEV3I4akVSNm9MbFJrc1RNY2RZRFN0UFRtUGUxYzhZU2Fjd0lKcmlaRWNwaXpQOGpkVjJUSHFETzZteW94X05kLWNuWEVWUVJ2WWZNbXZ4cEtGaldfN1lpb1I1c1pIa25oRjh0NlNYYURaNXBpV0pv?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-14T11:00:00+00:00", "published_display": "14 Jul 2026 11:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Heartbeam Inc. (BEAT) Stock Price | Live Quotes & Charts | NASDAQ", "summary": "This page provides live quotes and charts for Heartbeam Inc. (BEAT) stock, which is currently trading at $0.6369 with a slight decrease. It notes that there are no analyst ratings or earnings information currently available for the company. The rest of the page primarily consists", "url": "https://timothysykes.com/quote/BEAT/", "source_name": "timothysykes.com", "published_at": "2026-07-09T23:10:36", "published_display": "09 Jul 2026 23:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeartBeam (NASDAQ: BEAT) Completes Enrollment Ahead of Schedule in Heart Attack Detection Pilot Study", "summary": "HeartBeam (NASDAQ: BEAT) has completed patient enrollment ahead of schedule for its ALIGN-ACS pilot study, which evaluates the HeartBeam System for heart attack detection. The study enrolled 120 patients and data analysis is now underway, with results expected to be presented at ", "url": "https://www.theglobeandmail.com/investing/markets/stocks/BEAT/pressreleases/3059326/heartbeam-nasdaq-beat-completes-enrollment-ahead-of-schedule-in-heart-attack-detection-pilot-study/", "source_name": "The Globe and Mail", "published_at": "2026-07-05T00:41:03", "published_display": "05 Jul 2026 00:41", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nasdaq warns HeartBeam (NASDAQ: BEAT) over $1 minimum bid price rule", "summary": "HeartBeam, Inc. (NASDAQ: BEAT) has received a notice from Nasdaq stating that its common stock is not in compliance with the exchange's minimum $1.00 bid price requirement, having traded below this level for 30 consecutive business days. The company has 180 calendar days, until D", "url": "https://www.stocktitan.net/sec-filings/BEAT/8-k-heart-beam-inc-reports-material-event-e8a1369abf91.html", "source_name": "Stock Titan", "published_at": "2026-07-02T20:40:47", "published_display": "02 Jul 2026 20:40", "sentiment": "negative", "sentiment_pct": 36, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeartBeam Disclosed Failure to Satisfy a Continued Listing Rule or Standard", "summary": "HeartBeam (BEAT) received a Nasdaq deficiency notice on June 30, 2026, for failing to maintain a minimum bid price of $1.00 for 30 consecutive business days. The company has 180 days, until December 28, 2026, to regain compliance, with a possibility of an extension. This informat", "url": "https://www.tradingview.com/news/tradingview:c958b024bea56:0-heartbeam-disclosed-failure-to-satisfy-a-continued-listing-rule-or-standard/", "source_name": "TradingView", "published_at": "2026-07-02T20:40:47", "published_display": "02 Jul 2026 20:40", "sentiment": "negative", "sentiment_pct": 14, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Heartbeam, Inc. Warrant 2021-31.10.26 on HeartBeam Financial Disclosures & SEC Filings", "summary": "This page provides access to Heartbeam, Inc.'s SEC filings and other important company documents, such as Forms 10-K, 10-Q, and 8-K. Investors can review these disclosures to evaluate the company's financial performance and operational updates. The documents span from 2021 to 202", "url": "https://www.tradingview.com/symbols/NASDAQ-BEATW/documents/", "source_name": "TradingView", "published_at": "2026-07-02T19:11:35", "published_display": "02 Jul 2026 19:11", "sentiment": "positive", "sentiment_pct": 65, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeartBeam (BEAT) Advances Modern Cardiac Care, Expanding Use of ECG Data Outside of the Hospital", "summary": "HeartBeam (NASDAQ: BEAT) is developing technologies to expand the use of ECG data beyond hospital settings, focusing on timely and actionable insights for cardiac care. Their proprietary, FDA-cleared HeartBeam System is a portable, cable-free ECG system that synthesizes a 12-lead", "url": "https://finance.yahoo.com/healthcare/articles/heartbeam-beat-advances-modern-cardiac-174042972.html", "source_name": "Market source", "published_at": "2026-07-01T17:39:20", "published_display": "01 Jul 2026 17:39", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeartBeam completes enrollment in heart attack detection study", "summary": "HeartBeam, Inc. has completed patient enrollment in its ALIGN-ACS pilot study, evaluating its HeartBeam System for heart attack detection ahead of schedule. The study involved 120 patients in Serbia and its findings will inform a planned pivotal study in the U.S. and support a fu", "url": "https://www.investing.com/news/company-news/heartbeam-completes-enrollment-in-heart-attack-detection-study-93CH-4767485", "source_name": "Investing.com", "published_at": "2026-06-30T21:39:20", "published_display": "30 Jun 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeartBeam (BEAT) Completes Enrollment Ahead of Schedule in Heart Attack Detection Pilot Study", "summary": "HeartBeam (NASDAQ: BEAT) has successfully completed patient enrollment for its ALIGN-ACS pilot study, which evaluates the HeartBeam System for heart attack detection, ahead of its scheduled timeline. The study included 120 patients at two sites in Serbia, utilizing both standard ", "url": "https://www.newmediawire.com/news/heartbeam-beat-completes-enrollment-ahead-of-schedule-in-heart-attack-detection-pilot-study-7087440", "source_name": "NewMediaWire", "published_at": "2026-06-30T21:10:04", "published_display": "30 Jun 2026 21:10", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeartBeam (BEAT) FDA Approvals, PDUFA Dates & Drug Alerts 2026 $BEAT", "summary": "This article details the FDA approval process and regulatory events for HeartBeam (BEAT), focusing on two key therapies: ALIGN-ACS for heart attack detection and the HeartBeam system for comprehensive arrhythmia assessment. It highlights the recent completion of patient enrollmen", "url": "https://www.marketbeat.com/stocks/NASDAQ/BEAT/fda-events/?drug=ALIGNACS&anchor=fda-alignacs-2026-06-30", "source_name": "MarketBeat", "published_at": "2026-06-30T17:09:48", "published_display": "30 Jun 2026 17:09", "sentiment": "positive", "sentiment_pct": 70, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule", "summary": "HeartBeam, Inc. has completed patient enrollment in its ALIGN-ACS pilot study for heart attack detection ahead of schedule, evaluating its 3D ECG technology. Data analysis is currently underway, with full results expected to be presented at a cardiology conference later this year", "url": "https://www.businesswire.com/news/home/20260630151674/en/HeartBeam-Completes-Enrollment-in-Heart-Attack-Detection-Pilot-Study-Ahead-of-Schedule", "source_name": "Business Wire", "published_at": "2026-06-30T11:09:48", "published_display": "30 Jun 2026 11:09", "sentiment": "positive", "sentiment_pct": 73, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeartBeam (BEAT) Stock Sees Fair Value Cut As Analysts Weigh Dilution And Slower Ramp", "summary": "HeartBeam (BEAT) recently saw its fair value estimate cut by analysts from $5.08 to $3.83 per share, primarily due to recent equity offerings causing dilution and a slower-than-expected revenue ramp. Despite these reductions, some analysts maintain bullish ratings, citing a solid", "url": "https://finance.yahoo.com/markets/stocks/articles/heartbeam-beat-stock-sees-fair-130837826.html", "source_name": "Market source", "published_at": "2026-06-27T12:08:00", "published_display": "27 Jun 2026 12:08", "sentiment": "negative", "sentiment_pct": 29, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeartBeam, Inc. Actuals & Estimates (NASDAQ:BEAT)", "summary": "This article provides an in-depth financial overview of HeartBeam, Inc. (NASDAQ:BEAT), including its current stock price, historical performance, analyst forecasts, and key financial metrics like market capitalization, earnings, and revenue. It highlights a significant decrease i", "url": "https://www.tradingview.com/symbols/NASDAQ-BEAT/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-25T16:40:04", "published_display": "25 Jun 2026 16:40", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeartBeam (BEAT) Reorganizes to Accelerate Global Commercialization Strategy", "summary": "HeartBeam (NASDAQ: BEAT) announced a strategic reorganization to accelerate its global commercialization strategy for its cardiac monitoring technology. This includes streamlining decision-making, improving accountability, and reducing costs, with founder Branislav Vajdic, Ph.D.,", "url": "https://finance.yahoo.com/healthcare/articles/heartbeam-beat-reorganizes-accelerate-global-194000521.html", "source_name": "Market source", "published_at": "2026-06-25T03:09:42", "published_display": "25 Jun 2026 03:09", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Leadership shakeup as HeartBeam (NASDAQ: BEAT) reorganizes for global ECG push", "summary": "HeartBeam, Inc. (NASDAQ: BEAT) announced a strategic reorganization to accelerate global adoption of its ambulatory ECG signal platform and improve capital efficiency. CEO Robert P. Eno will depart on June 30, 2026, with Founder and President Branislav Vajdic, Ph.D., taking over ", "url": "https://www.stocktitan.net/sec-filings/BEAT/8-k-heart-beam-inc-reports-material-event-65ec711f0321.html", "source_name": "Stock Titan", "published_at": "2026-06-24T21:11:21", "published_display": "24 Jun 2026 21:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeartBeam Announces Strategic Shift to Accelerate Global Adoption of its Ambulatory ECG Signal Platform and Leadership Transition", "summary": "HeartBeam, Inc. has announced a strategic reorganization to accelerate the global adoption of its ambulatory ECG signal platform, moving beyond direct medical device sales to license its 3D ECG technology to established partners. The company aims to broaden its market reach, focu", "url": "https://www.businesswire.com/news/home/20260624011757/en/HeartBeam-Announces-Strategic-Shift-to-Accelerate-Global-Adoption-of-its-Ambulatory-ECG-Signal-Platform-and-Leadership-Transition", "source_name": "Business Wire", "published_at": "2026-06-24T20:11:21", "published_display": "24 Jun 2026 20:11", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeartBeam (NASDAQ: BEAT) Launches Study Focused on Testing Proprietary Patch Capable of Generating On-Demand 12-Lead ECG for Ischemia Detection", "summary": "HeartBeam (NASDAQ: BEAT) has initiated a pilot study to evaluate its proprietary on-demand 12-lead ECG patch for detecting coronary artery disease and ischemia. This technology aims to provide clinical-grade insights over extended periods, an advancement not previously possible w", "url": "https://www.tradingview.com/news/financewire:d138b2176094b:0-heartbeam-nasdaq-beat-launches-study-focused-on-testing-proprietary-patch-capable-of-generating-on-demand-12-lead-ecg-for-ischemia-detection/", "source_name": "TradingView", "published_at": "2026-06-23T17:42:06", "published_display": "23 Jun 2026 17:42", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeartBeam (BEAT) Launches Study Focused on Testing Proprietary Patch Capable of Generating On-Demand 12-Lead ECG for Ischemia Detection", "summary": "HeartBeam (NASDAQ: BEAT) has initiated a pilot study to evaluate its proprietary on-demand 12-lead ECG patch for detecting coronary artery disease and ischemia. This study aims to address the urgent and widespread health threat of coronary artery disease by providing a faster and", "url": "https://finance.yahoo.com/healthcare/articles/heartbeam-beat-launches-study-focused-181500690.html", "source_name": "Market source", "published_at": "2026-06-23T14:15:00", "published_display": "23 Jun 2026 14:15", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[8-K] HeartBeam, Inc. Reports Material Event", "summary": "HeartBeam, Inc. announced new compensation arrangements for its President, Founder, and Director, Dr. Branislav Vajdic, including a performance-based restricted stock unit (PRSU) award and a Transaction Bonus Agreement. The PRSUs, totaling 2,800,000 units, are contingent on achie", "url": "https://www.stocktitan.net/sec-filings/BEAT/8-k-heart-beam-inc-reports-material-event-67a8b1056ce0.html", "source_name": "Stock Titan", "published_at": "2026-06-23T05:39:35", "published_display": "23 Jun 2026 05:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BEATW | Heartbeam, Inc. Warrant Insider Trading", "summary": "This Quiver Quantitative page provides an overview of Heartbeam, Inc. Warrant (BEATW) focusing on insider trading activity, institutional holdings, analyst ratings, and company financials. It indicates no recent insider trading for this specific ticker and lists institutional own", "url": "https://www.quiverquant.com/stock/BEATW/insiders/", "source_name": "Quiver Quantitative", "published_at": "2026-06-21T21:09:44", "published_display": "21 Jun 2026 21:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Heartbeam Inc (BEATW) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of Heartbeam Inc (BEATW)'s dividend and stock split history. It states that no dividend data or stock split data is available for the company. The article also includes current stock price information and links to various financial news and analy", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-beatw/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-19T16:10:19", "published_display": "19 Jun 2026 16:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Heartbeam Inc (BEATW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article from TradingKey attempts to provide a revenue breakdown for Heartbeam Inc (BEATW), including business segments, regional revenue, and profit contribution. However, the article states that relevant data for these categories have not been disclosed by the company yet. ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-beatw/revenue", "source_name": "TradingKey", "published_at": "2026-06-19T09:11:02", "published_display": "19 Jun 2026 09:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeartBeam (NASDAQ: BEAT) seeks approval for 3M-share equity plan increase at 2026 meeting", "summary": "HeartBeam, Inc. (NASDAQ: BEAT) is seeking shareholder approval to amend its 2022 Equity Incentive Plan to increase the number of authorized shares by 3,000,000, bringing the total capacity to 14,900,000 shares. This proposal, discussed in a definitive proxy statement for the July", "url": "https://www.stocktitan.net/sec-filings/BEAT/def-14a-heart-beam-inc-definitive-proxy-statement-90b5fb217190.html", "source_name": "Stock Titan", "published_at": "2026-06-18T20:46:10", "published_display": "18 Jun 2026 20:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Heartbeam Inc (BEAT) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of Heartbeam Inc (BEAT), focusing on support, resistance, indicators, and moving averages. While relevant data for support and resistance have not been disclosed, the analysis covers various technical indicators like MACD, RSI, and KDJ, ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-beat/technical", "source_name": "TradingKey", "published_at": "2026-06-18T14:46:10", "published_display": "18 Jun 2026 14:46", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Heartbeam Inc (BEATW) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "This article from TradingKey provides an earnings forecast for Heartbeam Inc (BEATW), focusing on future EPS and revenue growth estimates. However, the report states that relevant data for financial forecasting metrics such as EPS, revenue, net profit, and EBIT have not been disc", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-beatw/earnings", "source_name": "TradingKey", "published_at": "2026-06-18T03:39:30", "published_display": "18 Jun 2026 03:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Heartbeam Inc (BEAT) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides historical payout information for Heartbeam Inc (BEAT) regarding dividends and stock splits. It states that Heartbeam Inc has not distributed any dividends over the past five years and has no recorded stock split data. The page also presents current stock pe", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-beat/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-17T21:10:43", "published_display": "17 Jun 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Heartbeam Inc (BEAT) Institutional Confidence", "summary": "This article from TradingKey provides a snapshot of institutional confidence in Heartbeam Inc (BEAT). It details key institutional shareholders and their shareholdings, noting changes for some, such as BlackRock and UBS Financial Services. The data offers insights into institutio", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-beat/sentiment", "source_name": "TradingKey", "published_at": "2026-06-17T20:10:43", "published_display": "17 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Heartbeam Inc (BEATW) Financial Health: Profitability & Balance Sheet Analysis", "summary": "The article provides an overview of Heartbeam Inc (BEATW) financial health, focusing on profitability and balance sheet analysis. It notes that relevant financial data regarding cash, assets, liabilities, revenue, operating profit, and cash flow has not yet been disclosed by the ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-beatw/financial-health", "source_name": "TradingKey", "published_at": "2026-06-17T09:11:15", "published_display": "17 Jun 2026 09:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeartBeam (BEAT) Study Shows Portable ECG Device Can Help Identify Heart Attack Risk", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/heartbeam-beat-study-shows-portable-150820463.html", "source_name": "NewMediaWire", "published_at": "2026-06-03T15:08:20+00:00", "published_display": "03 Jun 2026 15:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeartBeam reaches 4 U.S. markets through Cedars-Sinai-linked clinic", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNRW5YRWtHcExwRm85ZVhIUHVSSVZRXzdUTTJKM0ttUTg1YnAzT3NsRkVQODk2Mzk5ZmpFZThQQ0ZqalhnVHIzYklCTE1rNlRIVGpEQVJ6QnVaeEFLaWM4dFFGbXIxQUtMSndUbzlNSXM0Ymp0NHVLMjl1VjJQWldlYWFWWjB2YU5haDZqeUZLcThBY082T05ZMnowb0pfOVNKZWNTSjgtWDdXeU03Yml1Z0dEMDgyLUlQSlI3Zm1n?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeartBeam Announces Closing of $10 Million Public Offering of Common Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxOVVpPN051NE14MUp4ZFhlZVQ0bGtKZS01bmpnbVdpZVg1QTNNSXZxZktnb0w2SWRGU0U3NlpaNmpBR1pnanFhSGVmcGJLN1dEU2JEMEJLc3RrM3JMVVZDYlI5aElTQlhPTzJYMDFSV1BwZVU0eVRVbk5mZXNHOU9qelRXVUxaOE8tajhBQXBiemw5bjZmQVFUaUkzdXZJRGZ0eVZWZ1ZGSmFKenJJdTl1SllZRl9PajZtcm5kU0xRTW1pX003M0VIaU1Qbkh6UQ?oc=5", "source_name": "Business Wire", "published_at": "2026-04-16T07:00:00+00:00", "published_display": "16 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeartBeam Announces Pricing of $10 Million Public Offering of Common Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxObFl0T2lYQk1GQnV2Y3FNVnVHeWE5aFFaV3h1SU81X2Vud2tiOXBuRHgyQ1YzWnF5QmJ2R2RHaWpSZ1FqTDBuVWNGa0Q1SlZKYzB4T3dPNlZtejg5WWQzd0g4MmtoMlU4WWwyRGlNMG10d0xlUjJyVVdFeEZHei1LcGpsbzJSaVdzbTlweVowTk5mSjFFRGp2QzJjZy1Gbjl0N1YtaFA5ckk3ZGZhcFRUb3RmUDJjUXNfVWRaYTQ0eC1hbW54YVVJdUNMNV95UQ?oc=5", "source_name": "Business Wire", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeartBeam seeks fresh capital for FDA-cleared ECG rollout", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPTThGMkN4VVc4OXFlcnNjc2EwUHlvRG9veFBvSldWMVlCLVNaMWxSMEstSEdzel80WU1oRWRVUDRCX1luTVFFVnBHaFFLanBrR0ttMEtuMWRLMm9MdVQ4bk10WjBzcV9jaUZIcloxUm1RMzVfMmRuZEJpSHB3Rlp4Q2RyazVYcWt6RmpfRUw5MkM2TGVpT042LV9heUtzUG1XbEZNczhoQWZBRVk2SFY4?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-14T07:00:00+00:00", "published_display": "14 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New HeartBeam\u2013Mount Sinai project brings hospital-grade heart checks home", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxNR1lRcGltRk1UQkw0SV9YdjVrTW5YREpwb3ZLMkRPZGM3Y0ZwT2RFeVhZaURKV0JHU182UmtUYVBXaUxMSGFDUjFyTGl4c3J3LWd0MUJ5X3JqRU8zUVQ2V2ZCRXlWeXZwdlFwYVlVVTJVTmhLem14eW1fMWZvVG9Tdzl3VldjbkV0MXRNb3M3RzIwR0Q1VzZLUXVBQVlLLUtmdVU1R21HNVNaMzN1aVlFVTBKX2l2VEFub2tsSg?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HeartBeam raising $10M for FDA-cleared health tech with public offering", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxNdWhYRHNTTkxqTC1JSlpET1I4NkVyc09KYk5zcE5hN3hlWXpMNFlhUWpncTdFSGF6U0tvWTBSdmh0dHhBbUVCZFUwaXlVbHdXWl9LRzJWbFBiTk9JT3Y3SjV4RGVHSnRNczUxOC1TMjdMU0pzejllVF85eEVFVElBWG82Zk1ZVDVsTjZwVTRTT01laXlka2FXQVVYUGF4MGpaNFpVaWpiMDJ2elJ1QTJVci03QnhpWUhVSHpWSGtXLXVTYkpYRndmTjNaMThOY0YyTEpsWU5md21PaG1Dbm1R?oc=5", "source_name": "Cardiovascular Business", "published_at": "2025-02-13T08:00:00+00:00", "published_display": "13 Feb 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 99, "total_relevant": 40, "sentiment_summary": {"positive": 13, "negative": 6, "neutral": 21, "score": 54, "total": 40, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 81, "events": [{"event": "general", "label": "Market update", "weight": 13.2, "count": 24}, {"event": "earnings", "label": "Earnings", "weight": 5.5, "count": 10}, {"event": "analyst", "label": "Analyst action", "weight": 1.1, "count": 2}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 1.1, "count": 2}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}, {"event": "capital_return", "label": "Capital return", "weight": 0.55, "count": 1}], "positive_events": 13, "negative_events": 6}, "market_context": {"has_market_context": true, "latest_close": 0.56, "latest_week": "2026-07-17", "one_week_move": -7.6, "four_week_move": -26.4, "twelve_week_move": -38.1, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.685131, "market_dynamics_buy_signal": false, "relative_strength": -62.963291, "fair_value_gap": -69.4, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 37.6889, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-7.6% over one week, -26.4% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 63, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 8}, {"label": "TradingKey", "count": 7}, {"label": "Business Wire", "count": 5}, {"label": "TradingView", "count": 4}, {"label": "Market source", "count": 4}, {"label": "Investing.com", "count": 2}, {"label": "NewMediaWire", "count": 2}, {"label": "ChartMill", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 40}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 24}, {"label": "Earnings", "count": 10}, {"label": "Analyst action", "count": 2}, {"label": "Regulatory and legal", "count": 2}, {"label": "Balance sheet", "count": 1}, {"label": "Capital return", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "54/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "81/100 classification confidence."}, {"label": "Company focus", "value": "40", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-7.6% over one week, -26.4% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Negative", "tone": "negative", "text": "Halliburton Co. (NYSE:HAL) Reports In-Line Q2 Earnings and Revenue Beat, Shares Fall on Geopolitical Risks"}], "updated_at": "2026-07-22T02:48:22.440065+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}